The American Society of Clinical Oncology (ASCO) has reviewed complications associated with immune checkpoint inhibitor therapy.
Patient selection: episcleritis following therapy with an immune checkpoint inhibitor
Parameters:
(1) symptoms
(2) deterioration in vision
|
Symptoms
|
Vision
|
Grade
|
|
asymptomatic
|
not changed
|
G1
|
|
symptomatic
|
better than 20/40
|
G2
|
|
symptomatic
|
worse than 20/40 but better than 20/200
|
G3
|
|
symptomatic
|
worse than 20/200
|
G4
|
The diagnosis requires exclusion of other causes that can explain the findings.
